Life Molecular Imaging GmbH (LMI) announces today that florbetaben (18F) has been granted orphan designation by the European ...

However, few medicines are approved for ATTR-wt. GlobalData estimates that vutrisiran’s entrance into the ATTR-wt market will ...

Florbetaben (18F) has been granted Orphan drug designation for the diagnosis of ATTR amyloidosisFlorbetaben (18F) previously received orphan drug designation as a diagnostic agent for the management ...

Jill White, Certified Life and Business Coach, international speaker, and founder of Overflow Coaching, is proud to announce ...

Keymed Biosciences Inc. (HKEX: 02162) today announced that Prof. Jun Shi's research team from the Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences (Institute of ...

Ratings for Alnylam Pharmaceuticals ALNY -1.28% Get Free Report were provided by 18 analysts in the past three months, ...

The 12-month price targets assessed by analysts reveal further insights, featuring an average target of $51.6, a high ...